Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma

BMC Urol. 2021 Dec 2;21(1):167. doi: 10.1186/s12894-021-00932-2.

Abstract

Background: One of the major concerns of patients with upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy is intravesical recurrence (IVR). The purpose of the present study was to investigate the predictive risk factors for IVR after retroperitoneoscopic nephroureterectomy (RNU) for UTUC.

Methods: Clinicopathological and surgical information were collected from the medical records of 73 patients treated with RNU for non-metastatic UTUC, without a history of or concomitant bladder cancer. The association between IVR after RNU and clinicopathological and surgery-related factors, including preoperative urine cytology and pneumoretroperitoneum time, was analyzed using the Fisher exact test.

Results: During the median follow-up time of 39.1 months, 18 (24.7%) patients had subsequent IVR after RNU. The 1- and 3-year IVR-free survival rates were 85.9% and 76.5%, respectively. The Fisher exact test revealed that prolonged pneumoretroperitoneum time of ≥ 210 min was a risk factor for IVR in 1 year after RNU (p = 0.0358) and positive urine cytology was a risk factor for IVR in 3 years after RNU (p = 0.0352).

Conclusions: In UTUC, the occurrences of IVR in 1 and 3 years after RNU are highly probable when the pneumoretroperitoneum time is prolonged (≥ 210 min) and in patients with positive urine cytology, respectively. Strict follow-up after RNU is more probable recommended for these patients.

Keywords: Intravesical recurrence; Pneumoretroperitoneum time; Retroperitoneoscopic nephroureterectomy; Upper urinary tract; Urine cytology; Urothelial carcinoma.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Transitional Cell / epidemiology*
  • Carcinoma, Transitional Cell / surgery*
  • Female
  • Humans
  • Kidney Neoplasms / surgery*
  • Laparoscopy*
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / epidemiology*
  • Neoplasms, Second Primary / epidemiology*
  • Nephroureterectomy / methods*
  • Retroperitoneal Space
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Ureteral Neoplasms / surgery*
  • Urinary Bladder Neoplasms / epidemiology*